Stock Information
Abcellera Biologics Inc (ABCL)
Ticker Symbol: ABCL
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $3,490.44 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.54
Revenue (TTM): $0.22 M
Dividend Yield: N/A
ROE: -17.49%
Latest News
-
Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
Thu, Sep 24, 2026 2:59 PM
-
Goldman Sachs Reinstates Neutral on AbCellera Biologics, Announces $13 Price Target
Thu, Sep 24, 2026 8:02 AM
-
ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know
Tue, Sep 22, 2026 2:17 PM
Key Financials
Financial data not available
